<DOC>
<DOCNO>
EP-0007930
</DOCNO>
<TEXT>
<DATE>
19800220
</DATE>
<IPC-CLASSIFICATIONS>
C07D-237/20 A61K-31/50 C07D-237/00 A61P-9/00 A61P-9/12 <main>C07D-237/20</main> C07D-237/22 
</IPC-CLASSIFICATIONS>
<TITLE>
arylpyridazinylhydrazine salt, processes for preparing it and pharmaceutical compositions containing it.
</TITLE>
<APPLICANT>
smith kline french labgb<sep>smith kline & french laboratories limited  <sep>smith kline &amp; french laboratories limitedmundellswelwyn garden city hertfordshire, al7 1eygb<sep>smith kline & french laboratories limited<sep>
</APPLICANT>
<INVENTOR>
burpitt brian eric<sep>graham michael james<sep>roe anthony maitland<sep>burpitt, brian eric<sep>graham, michael james<sep>roe, anthony maitland<sep>burpitt, brian eric36 brook drivestevenage hertfordshiregb<sep>graham, michael james3 stoneycroftwelwyn garden city hertfordshiregb<sep>roe, anthony maitland10 lodge drivehatfield hertfordshiregb<sep>burpitt, brian eric<sep>graham, michael james  <sep>roe, anthony maitland <sep>burpitt, brian eric36 brook drivestevenage hertfordshiregb<sep>graham, michael james3 stoneycroftwelwyn garden city hertfordshiregb<sep>roe, anthony maitland10 lodge drivehatfield hertfordshiregb<sep>
</INVENTOR>
<ABSTRACT>
a process for preparing a new compound, racemic  3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydraÂ­ zino-pyridazine dihydrochloride monohydrate, which is a  useful antihypertensive and which can be recrystallised  with consistent water content and which is stable under  normal conditions of temperature and humidity.  
</ABSTRACT>
</TEXT>
</DOC>
